News

Cipla launches Cipremi for treatment for patients with severe COVID-19 disease

It is claimed to be the only US FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection

Read More

Jun 23, 2020

By : Team ABLE

Praj, Lygos to co-develop advanced lactic acid yeast technology for bio-based products

Lygos will provide its proprietary yeast platform to Praj for jointly developing into various solutions for commercial applications.

Read More

Jun 23, 2020

By : Team ABLE

IIT Madras Researchers show ways to improve efficacy of anti-cancer treatments

The research team is now exploring collaborations with cancer hospitals to try their ‘simple timing’ strategy to enhance the effectiveness of cancer treatment

Read More

Jun 22, 2020

By : Team ABLE

Glenmark receives regulatory approval for oral antiviral drug Favipiravir; to market it under the brand name FabiFlu

FabiFlu is the first oral Favipiravir-approved medication in India for the treatment of COVID-19.

Read More

Jun 22, 2020

By : Team ABLE

Marc Princen appointed new Global CEO for Mundipharma

In his new role, Mr Princen will be responsible for all of Mundipharma’s strategic and operational matters globally.

Read More

Jun 17, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights